Pfizer

Pfizer Inc. (PFE) is a global biopharmaceutical company founded in 1849, dedicated to discovering, developing, manufacturing, marketing, distributing, and selling medicines and vaccines worldwide. The company operates in various therapeutic areas, including cardiovascular health, infectious diseases, and immunology. Notable products in Pfizer's portfolio include Eliquis for cardiovascular conditions, the Prevnar family of vaccines for pneumococcal diseases, and Comirnaty, the widely recognized COVID-19 vaccine developed in partnership with BioNTech. ​AnaChart+1StockAnalysis+1

Over the past 52 weeks, Pfizer's stock has experienced a high of $34.42 and a low of $25.20. ​Barron's

Analyst recommendations for Pfizer are as follows:​StockAnalysis+2AnaChart+2MarketBeat+2

• Buy: 8 analysts​MarketBeat
• Hold: 8 analysts​MarketBeat+1AnaChart+1
• Sell: 1 analyst​

This results in a consensus rating of "Moderate Buy" based on evaluations from 17 Wall Street analysts. ​MarketBeat

Subscribe to our API. See Strong Buy and Sell Signals the Day after They Occur!